WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS

被引：0
|
作者：
Rubin, David T.
Modesto, Irene
Vermeire, Severine
Danese, Silvio
Ng, Siew C.
Kwok, Kenneth K.
Koram, Nana
Jones, Thomas V.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
130
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [31] Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    [J]. Rheumatology and Therapy, 2024, 11 (1) : 221 - 222
  • [32] The safety profile of vedolizumab in ulcerative colitis and Crohn's disease: 4 years of post-marketing data
    Russell, Cohen D.
    Fatima, Bhayat
    Aimee, Blake
    Simon, Travis
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S4 - S4
  • [33] Pharmacology and safety of tofacitinib in ulcerative colitis
    Lopez-Sanroman, Antonio
    Esplugues, Juan, V
    Domenech, Eugeni
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (01): : 39 - 48
  • [34] POST-MARKETING SURVEILLANCE OF DRUGS
    LAWSON, DH
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6189): : 546 - 546
  • [35] Post-marketing surveillance of sertindole
    Toumi, M
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 : S33 - S35
  • [36] Post-marketing surveillance of buprenorphine
    Ray, R
    Pal, H
    Kumar, R
    Maulick, P
    Mangla, R
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (09) : 615 - 619
  • [37] PROBLEMS OF POST-MARKETING SURVEILLANCE
    CASTLE, WM
    NICHOLLS, JT
    DOWNIE, CC
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) : 581 - 585
  • [38] POST-MARKETING SURVEILLANCE OF DRUGS
    HARCUS, AW
    WARD, AE
    SMITH, DW
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6194): : 867 - 867
  • [39] POST-MARKETING DRUG SURVEILLANCE
    WALDEN, RJ
    PRICHARD, BNC
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) : 191 - 192
  • [40] A PRESCRIPTION FOR POST-MARKETING SURVEILLANCE
    ROUTMAN, KD
    [J]. DRUG & COSMETIC INDUSTRY, 1980, 126 (06): : 60 - 64
12345